Abzena plc
CAMBRIDGE, X0 · Founded 2014 · CIK 0001653673 · Biotech · Acquired
Integrated contract development and manufacturing organization (CDMO) and contract research organization (CRO) for antibody-based therapeutics, antibody-drug conjugates, antibody-oligonucleotide conju
abzena.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $4.3M
- 2 Form D · Dec 2015
- 130 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152016
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $700,000 | |
| Private capital raised | Form D · SEC | $3,603,185 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2462 | Actym Therapeutics, Inc. | — | $25M |
| 2463 | Verseon Corp | — | $25M |
| 2464 | Pharmazz, Inc. | — | $25M |
| 2465 | Abzena plc | — | $4.3M |
| 2466 | CURADEL SURGICAL INNOVATIONS, INC. | — | $24M |
| 2467 | Vaxart, Inc. | — | $23M |
| 2468 | PULMOTECT, INC | — | $22M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Matthew BakerExecutive Officer
- Anthony BramptonDirector
- Campbell BunceExecutive Officer
- William BurtDirector · Executive Officer
- Kenneth CunninghamDirector
- Peter GrantDirector
- Nareshkumar JainExecutive Officer
- Anker LundemoseDirector
- Jim MillsExecutive Officer
- Gary PierceExecutive Officer
- Leigh PierceExecutive Officer
- Nigel PitchfordDirector
- Julian SmithDirector · Executive Officer
- Sally WatermanExecutive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.